For Immediate Release

Contact:
ResearchPoint
Elisa Murphy
emurphy@researchpoint.com

RESEARCHPOINT APPOINTS MATTHEW W. WALKER, EXECUTIVE VICE PRESIDENT, BUSINESS DEVELOPMENT & MARKETING

Austin, TX- January 3, 2007 –ResearchPoint, a full-service, privately-owned, contract research organization serving the pharmaceutical, biotechnology, and medical device industries, announces the appointment of Matthew W. Walker to its leadership team as Executive Vice President, Business Development & Marketing. In addition to sales, marketing, and business development responsibilities, Mr. Walker will lead strategic and organizational alignment and growth, while coordinating development and positioning of ResearchPoint’s service lines. 

Mr. Walker joined ResearchPoint from Hart InterCivic, Inc.  At Hart, Matt managed multiple business units, culminating in the position of Senior Vice President and General Manager, responsible for launching and managing new business initiatives. He brings nearly two decades of experience to ResearchPoint in project operations, P&L ownership, and operations management, and has a background in health care consulting from Deloitte Consulting.

“We welcome the strategic vision, leadership, and business savvy Matt brings to ResearchPoint,” remarks John Farinacci, President and CEO of ResearchPoint. “As the entire industry perseveres to improve the development process, customers are looking to technology to enhance efficiencies and outcomes.  We believe that Matt’s insight and experience will bolster ResearchPoint’s ability to accommodate their expectations. We are pleased to have him at ResearchPoint as a member of our Executive Team”

Mr. Walker received his BA in Economics from Stanford and his MBA from the Kellogg Graduate School of Management, Northwestern University.

About ResearchPoint
ResearchPoint is a contract research organization offering global reach with a customer-centric, individualized approach.  The ResearchPoint team uses a continuum model of integrated clinical development services to expedite product development and improve the outsourcing experience for customers and investigators.